Table 4.
Comparison of clinical data for different LDL-C levels
| Overall (n = 216) |
LDL-C < 2.51 mmol/L (n = 123) |
LDL-C ≥ 2.51 mmol/L (n = 93) | p value | ||
|---|---|---|---|---|---|
| General information | |||||
| Age, year | 64.00 (56.00–71.00) | 64.00 (55.00–70.00) | 65.00 (56.00–72.00) | 0.181 | |
| Male | 172 (79.6) | 100 (81.3) | 72 (77.4) | 0.483 | |
| Current smoker | 74 (34.3) | 39 (31.7) | 35 (37.6) | 0.363 | |
| Hypertension | 128 (59.3) | 52 (55.9) | 76 (61.8) | 0.384 | |
| Diabetes mellitus | 68 (31.5) | 42 (34.1) | 26 (28.0) | 0.332 | |
| LVEF, % | 56.00 (49.25-61.00) | 57.00 (51.00–61.00) | 56.00 (44.00-59.50) | 0.211 | |
| Creatinine, µmol/L | 84.00 (70.00-100.00) | 85.00 (70.00-100.00) | 84.00 (70.00-101.00) | 0.871 | |
| eGFR, mL/min/1.73 m2 | 103.27 (83.69-129.94) | 101.77 (84.98-129.81) | 104.20 (83.50-133.29) | 0.687 | |
| eGFR < 60, mL/min/1.73 m2 | 15 (6.9) | 6 (4.9) | 9 (9.7) | 0.169 | |
| Fasting blood glucose, mmol/L | 5.75 (4.91–6.77) | 5.64 (4.76–6.59) | 5.83 (5.10–6.93) | 0.190 | |
| TG, mmol/L | 1.69 (1.24–2.56) | 1.58 (1.17–2.39) | 1.87 (1.31–2.75) | 0.044 | |
| TC, mmol/L | 3.88 (3.42–4.83) | 3.57 (3.21–3.87) | 4.87 (4.39–5.70) | < 0.001 | |
| HDL-C, mmol/L | 1.12 ± 0.24 | 1.13 ± 0.24 | 1.09 ± 0.25 | 0.239 | |
| APOA1, g/L | 1.20 (1.07–1.33) | 1.18 (1.07–1.31) | 1.23 (1.08–1.37) | 0.157 | |
| APOB, g/L | 0.73 (0.60–0.90) | 0.62 (0.55–0.71) | 0.93 (0.81–1.08) | < 0.001 | |
| APOB/A1 | 0.61 (0.49–0.77) | 0.52 (0.44–0.61) | 0.75 (0.63–0.96) | < 0.001 | |
| Stent age, months | 48.00 (25.25-84.00) | 48.00 (24.00–84.00) | 60.00 (25.50–91.50) | 0.557 | |
| Medication at restenosis | |||||
| Aspirin | 176 (81.5) | 105 (85.4) | 71 (76.3) | 0.091 | |
| Statin | 183 (84.7) | 106 (86.2) | 77 (82.8) | 0.494 | |
| ACEI/ARB | 176 (81.5) | 105 (85.4) | 71 (76.3) | 0.091 | |
| β-blocker | 179 (82.9) | 103 (83.7) | 76 (81.7) | 0.697 | |
| Insulin | 12 (5.6) | 8 (6.5) | 4 (4.3) | 0.484 | |
Data are expressed as the median (interquartile range), mean ± SD, or n (%). ACEI: angiotensin-converting enzyme inhibitor; APO: apolipoprotein; ARB: angiotensin receptor blocker; eGFR, estimated glomerular filtration rate; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; LVEF: left ventricular ejection fraction; TC: total cholesterol; TG: triglyceride